Epcl.Psx
EPCL.PSX operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
Business. EPCL.PSX operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
Analyst recommendations
2 analysts · consensus SellAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
EPCL.PSX operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 2.41, indicating a significant reliance on debt financing. Despite a current ratio of 1.46, which suggests the company can cover its short-term liabilities, the negative net cash position after subtracting total debt raises liquidity concerns.
Profitability metrics are weak, with a return on equity of -16.66% and a return on assets of -3.32%, both well below the typical performance of the Commodity Chemicals industry. These figures indicate that the company is not generating sufficient returns to cover its cost of capital or asset base, which is a red flag for investors.
Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data, but the lack of segment-specific revenue breakdowns suggests a potential concentration risk. The absence of detailed geographic revenue distribution also limits the ability to assess regional exposure and diversification.
The company's growth trajectory is uncertain, with no clear revenue growth or decline indicated in the provided data. The free cash flow is negative at -3.54 billion, and capital expenditures are also negative, suggesting a lack of investment in future growth. This is further compounded by the company's net loss of 3.90 billion, which indicates a challenging operating environment.
Risk factors include a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential difficulties in meeting short-term obligations. The company has not issued any recent dilutive events, and the dilution risk remains low, although the negative free cash flow could necessitate future equity raises.
Recent events and filings do not provide specific details on new projects or strategic shifts, but the negative net income and weak cash flow metrics suggest ongoing operational challenges. The company's financial health is under pressure, and without significant improvements in profitability or liquidity, the outlook remains uncertain.
- EPCL.PSX is operating at a net loss with a significant debt burden, indicating financial distress.
- The company's return on equity and return on assets are negative, suggesting poor capital efficiency and asset utilization.
- The company's liquidity position is concerning, with a negative net cash position after subtracting total debt.
- Free cash flow is negative, and capital expenditures are also negative, indicating a lack of investment in future growth.
- The company's growth trajectory is unclear, with no clear revenue growth or decline indicated in the provided data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- EPCL.PSX Market data — financials · 2026-05-27
- Engro Polymer & Chemicals Ltd Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Jahangir PirachaChief Executive Officer, Executive Director